The restitution of Nrf2 hepatic activity by the Fer-1 treatment is accompanied by the recovery of the examined ferroptosis-related Nrf2 targets in the liver, thus supporting our hypothesis about the importance of Nrf2 signaling in the determination of hepatocytes’ ferroptotic phenotype in diabetes. Here, NFE2L2 is linked to diabetes mellitus.